Notably, our Cox regression analysis identified several clinical predictors associated with a shorter time to BM development, including post-menopausal status, Hispanic or Arabic ethnicity, and the ER+/HER2+ tumor subtype. This evidence concerns the gene ESR1 and neoplasm.